CompuMed (CMPD) Stock Price, News & Analysis
Company Description
CompuMed (OTC Link: CMPD) is classified in the health information services industry within the Healthcare sector and carries a market capitalization of $9.1M.
CMPD has gained 51.3% over the past year. Shares last traded at $6.90.
This page collects what Stock Titan holds for CMPD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CompuMed (CMPD) stock last closed at $6.90. Over the past 12 months, the stock has gained 51.3%. At a market capitalization of $9.1M, CMPD is classified as a micro-cap stock with approximately 1.3M shares outstanding.
Latest News
CompuMed has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 4 with negative movement. Key topics include management, earnings, stock split. View all CMPD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in CompuMed (CMPD) currently stands at 5.1 thousand shares, down 0.5% from the previous reporting period, representing 0.4% of the shares outstanding.
Days to Cover History
Days to cover for CompuMed (CMPD) currently stands at 3.6 days, up 33.3% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 57.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 17.5 days.
CMPD Company Profile & Sector Positioning
CompuMed (CMPD) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CMPD often look at related companies in the same sector, including Careview Comm (CRVW), Comprehensive Healthcare Systems (CMHSF), AI / ML Innovations (AIMLF), DiagnaMed Holdings Corp (DGNMF), and Imaging (IQAIF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CMPD's relative position within its industry.